These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 23667480)

  • 21. Picalm reduction exacerbates tau pathology in a murine tauopathy model.
    Ando K; De Decker R; Vergara C; Yilmaz Z; Mansour S; Suain V; Sleegers K; de Fisenne MA; Houben S; Potier MC; Duyckaerts C; Watanabe T; Buée L; Leroy K; Brion JP
    Acta Neuropathol; 2020 Apr; 139(4):773-789. PubMed ID: 31925534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early intervention of tau pathology prevents behavioral changes in the rTg4510 mouse model of tauopathy.
    Wang X; Smith K; Pearson M; Hughes A; Cosden ML; Marcus J; Hess JF; Savage MJ; Rosahl T; Smith SM; Schachter JB; Uslaner JM
    PLoS One; 2018; 13(4):e0195486. PubMed ID: 29624602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central role for p62/SQSTM1 in the elimination of toxic tau species in a mouse model of tauopathy.
    Ono M; Komatsu M; Ji B; Takado Y; Shimojo M; Minamihisamatsu T; Warabi E; Yanagawa T; Matsumoto G; Aoki I; Kanaan NM; Suhara T; Sahara N; Higuchi M
    Aging Cell; 2022 Jul; 21(7):e13615. PubMed ID: 35662390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The ordered assembly of tau is the gain-of-toxic function that causes human tauopathies.
    Goedert M
    Alzheimers Dement; 2016 Oct; 12(10):1040-1050. PubMed ID: 27686274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bezafibrate administration improves behavioral deficits and tau pathology in P301S mice.
    Dumont M; Stack C; Elipenahli C; Jainuddin S; Gerges M; Starkova N; Calingasan NY; Yang L; Tampellini D; Starkov AA; Chan RB; Di Paolo G; Pujol A; Beal MF
    Hum Mol Genet; 2012 Dec; 21(23):5091-105. PubMed ID: 22922230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauopathy model.
    Shiryaev N; Jouroukhin Y; Giladi E; Polyzoidou E; Grigoriadis NC; Rosenmann H; Gozes I
    Neurobiol Dis; 2009 May; 34(2):381-8. PubMed ID: 19264130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A unique tau conformation generated by an acetylation-mimic substitution modulates P301S-dependent tau pathology and hyperphosphorylation.
    Ajit D; Trzeciakiewicz H; Tseng JH; Wander CM; Chen Y; Ajit A; King DP; Cohen TJ
    J Biol Chem; 2019 Nov; 294(45):16698-16711. PubMed ID: 31543505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies.
    Dejanovic B; Huntley MA; De Mazière A; Meilandt WJ; Wu T; Srinivasan K; Jiang Z; Gandham V; Friedman BA; Ngu H; Foreman O; Carano RAD; Chih B; Klumperman J; Bakalarski C; Hanson JE; Sheng M
    Neuron; 2018 Dec; 100(6):1322-1336.e7. PubMed ID: 30392797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acceleration and persistence of neurofibrillary pathology in a mouse model of tauopathy following anesthesia.
    Planel E; Bretteville A; Liu L; Virag L; Du AL; Yu WH; Dickson DW; Whittington RA; Duff KE
    FASEB J; 2009 Aug; 23(8):2595-604. PubMed ID: 19279139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model.
    Yoshiyama Y; Higuchi M; Zhang B; Huang SM; Iwata N; Saido TC; Maeda J; Suhara T; Trojanowski JQ; Lee VM
    Neuron; 2007 Feb; 53(3):337-51. PubMed ID: 17270732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tau phosphorylation and aggregation as a therapeutic target in tauopathies.
    Badiola N; Suárez-Calvet M; Lleó A
    CNS Neurol Disord Drug Targets; 2010 Dec; 9(6):727-40. PubMed ID: 20942789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The direct role of 5-lipoxygenase on tau pathology, synaptic integrity and cognition in a mouse model of tauopathy.
    Vagnozzi AN; Giannopoulos PF; Praticò D
    Transl Psychiatry; 2017 Dec; 7(12):1288. PubMed ID: 29249809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tetrandrine ameliorates cognitive deficits and mitigates tau aggregation in cell and animal models of tauopathies.
    Tong BC; Huang AS; Wu AJ; Iyaswamy A; Ho OK; Kong AH; Sreenivasmurthy SG; Zhu Z; Su C; Liu J; Song J; Li M; Cheung KH
    J Biomed Sci; 2022 Oct; 29(1):85. PubMed ID: 36273169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cornel Iridoid Glycoside Regulates Modification of Tau and Alleviates Synaptic Abnormalities in Aged P301S Mice.
    Yang CC; Luo Y; Guo KW; Zheng CC; Li L; Zhang L
    Curr Med Sci; 2020 Dec; 40(6):1040-1046. PubMed ID: 33428131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intracerebral injection of preformed synthetic tau fibrils initiates widespread tauopathy and neuronal loss in the brains of tau transgenic mice.
    Peeraer E; Bottelbergs A; Van Kolen K; Stancu IC; Vasconcelos B; Mahieu M; Duytschaever H; Ver Donck L; Torremans A; Sluydts E; Van Acker N; Kemp JA; Mercken M; Brunden KR; Trojanowski JQ; Dewachter I; Lee VM; Moechars D
    Neurobiol Dis; 2015 Jan; 73():83-95. PubMed ID: 25220759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of Calpain Protects Against Tauopathy in Transgenic P301S Tau Mice.
    Liu M; Wang L; Gao J; Dong Q; Perry G; Ma X; Wang X
    J Alzheimers Dis; 2019; 69(4):1077-1087. PubMed ID: 31156179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short Fibrils Constitute the Major Species of Seed-Competent Tau in the Brains of Mice Transgenic for Human P301S Tau.
    Jackson SJ; Kerridge C; Cooper J; Cavallini A; Falcon B; Cella CV; Landi A; Szekeres PG; Murray TK; Ahmed Z; Goedert M; Hutton M; O'Neill MJ; Bose S
    J Neurosci; 2016 Jan; 36(3):762-72. PubMed ID: 26791207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Onset of hippocampal network aberration and memory deficits in P301S tau mice are associated with an early gene signature.
    Przybyla M; van Eersel J; van Hummel A; van der Hoven J; Sabale M; Harasta A; Müller J; Gajwani M; Prikas E; Mueller T; Stevens CH; Power J; Housley GD; Karl T; Kassiou M; Ke YD; Ittner A; Ittner LM
    Brain; 2020 Jun; 143(6):1889-1904. PubMed ID: 32375177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complement C3a receptor antagonist alleviates tau pathology and ameliorates cognitive deficits in P301S mice.
    Yao Y; Chang Y; Li S; Zhu J; Wu Y; Jiang X; Li L; Liu R; Ma R; Li G
    Brain Res Bull; 2023 Aug; 200():110685. PubMed ID: 37330021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deletion of murine tau gene increases tau aggregation in a human mutant tau transgenic mouse model.
    Ando K; Leroy K; Heraud C; Kabova A; Yilmaz Z; Authelet M; Suain V; De Decker R; Brion JP
    Biochem Soc Trans; 2010 Aug; 38(4):1001-5. PubMed ID: 20658993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.